Based on our findings, the CMV promoter may model genes such as cannabinoid receptor 1, cyclic AMP phosphoprotein, and G protein-coupled receptor 6 which display the largest decreases in transcription early in the progression of HD [21]. The gene discussed is CNR1; the disease is Huntington disease.